Carboplatin, vindesine, 5-fluorouracil-leucovorin and 13-cis retinoic acid in the treatment of advanced non-small cell lung cancer. A phase II study

Clinica Terapeutica

Volumn 150, Issue 4, 1999, Pages 269-274

  Recchia, Francesco ^a,b   De Filippis, S ^b   Pompili, P L ^a   Rosselli, M ^a   Saggio, G ^b   Ciorra, A ^a   Piccinini, M ^a   Rea, S ^a  

^a CROFI   (Italy)

^b NONE

Author keywords

13 cis retinoic acid; 5 fluorouracil; Carboplatin; Non small cell lung cancer; Vindesine

Indexed keywords

CARBOPLATIN; FLUOROURACIL; FOLINIC ACID; ISOTRETINOIN; VINDESINE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; ILEUS; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER TOXICITY; LUNG NON SMALL CELL CANCER; MALE; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; THROMBOCYTOPENIA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUOROURACIL; HUMANS; ISOTRETINOIN; LEUCOVORIN; LUNG NEOPLASMS; MALE; MIDDLE AGED; TOXICITY TESTS; VINDESINE; WORLD HEALTH ORGANIZATION;

EID: 0032736036     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. th ed), Philadelphia, Lippincott-Raven 858-911, 1997
2. Bunn PA: The expanding role of cisplatin in the treatment of non-small cell lung cancer. Semin Oncol 16: 10-21, 1989 (Suppl.6)
3. Non small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 311: 899-909, 1995
4. Lilembaum RC, Langenberg P, Dickersin K: Single agent versus combination chemotherapy in patients with advanced non small cell lung carcinoma: a meta-analysis of response, toxicity and survival. Cancer 82: 116-126, 1998
5. Bonomi PD, Finkelstein DM, Ruckdeschel JC, et al.: Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. J Clin Oncol 7: 1602-1613, 1989
6. Joss RA, Cavall F, Goldrish A, et al.: New agents in non-small-cell lung cancer. Cancer Treat Rev 11: 205-223, 1984
7. Shabel FM, Trader MW, Laster WR, et al.: Cis-dichlorodiam-mineplatinum combination chemotherapy and cross-resistance studies with tumor of the mice. Cancer Treat Rep 63: 1459-1473, 1979
8. Rustum YM, Trave F, Zakrzewski SF, et al.: Biochemical and pharmacologic basis for potentiation or 5-fluorouracil action by leucovorin. NCI monograph number 5: 165-170, 1987
9. Sporn MB, Dunlop NM, Newton DL, Smith JM: Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 35: 1332-1338, 1976
10. Srikland S, Mahdavi V: The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15: 393-403, (suppl. 1)
11. Lotan R: Effects of vitamin A and its analogues (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 605: 33-91, 1980
12. Sporn MB, Roberts AB: Role of retinoids in differentiation and carcinogenesis. Cancer Res 43: 3034-3040, 1983
13. Huang ME, Ye YC, Chen SR, et al.: Use of all trans retinoic acid in the treatment of acute promyelocytic leukemia. Clinical results. Blood 76: 567-572, 1988
14. Hong WK, Lippman SM, Itri LM, et al.: Prevention of secondary primary tumor with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J of Med 323: 795-801, 1990
15. Pastorino U, Infante M, Maioli M et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 11: 1216-1222, 1993
16. Spear G, Paulnock D, Jordan R, et al.: Enhancement of monocyte class I and II histocompatibility antigen expression in man by in vivo beta-interferon. Clin Exper Immunol 69: 107-115, 1987
17. Prabhala RH, Garenwal HS, Hicks MJ, et al.: The effects of 13-cis-Retinoic acid and beta-carotene on cellular immunity in humans. Cancer 67: 1556-1560, 1991
18. WHO: Handbook for Reporting Results of cancer treatment. (Offset publication 48). WHO, Geneva, 1979
19. Gehan EA: The determination of the number of patients required in a preliminary and follow up trial of a new chemotherapy agent. J Chron Dis 13: 346-353, 1961
20. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Ass 53: 457-481, 1958
21. Recchia F, Rea S, Corrao G, et al.: Sequential chemotherapy, beta interferon, retinoids and tamoxifen in the treatment of metastatic breast cancer. A pilot study. European Journal of Cancer 31 A: 1887-1888, 1995
22. Recchia F, Sica G, De Filippis S, et al.: Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer. Anticancer Research, 17: 3761-3766, 1997
23. Gralla RT, Kors MG. Chemotherapy in non-small-cell lung cancer. Results of recent trials. Semin Oncol 15: 2-5, 1988
24. Mandanas R, Einhorn LH, Wheeler B, et al.: Carboplatin (CBDCA) plus alpha interferon in metastatic non-small cell lung cancer. Am J Clin Oncol 16: 519-521, 1993
25. Ellis PA, Talbot DC, Nicolson Mcet, et al.: A pilot study of mitomycin, cisplatin and continuous infusion 5-fluorouracil (MCF) in advanced non-small-cell lung cancer. Br J Cancer 71: 1315-1318, 1995
26. Tsuchiya S, Minato K, Nakano H, et al.: A phase II study of 72-hour continuous infusion consisting of cisplatin and 5-fluorouracil for treatment of non-small-cell lung cancer. Oncology 52: 246-50, 1995
27. Lotan R, XU X-C, Lippman SM, et al.: Suppression of retinoic acid receptor-b in premalignant oral lesions and its up-regulation by isotretinoin. N Eng J Med 332: 1405-410, 1995
28. Marsh W, Center MS: Dimethylsulfoxide, retinoic acid and 12-O-tetra-decanoylphorbol-13-acetate induce a selective decrease in the phosphorylation of P150, a surface membrane phosphoprotein of HL-60 cells resistant to Adriamycin. Biochem Biophys Res Commun 138: 9-16, 1986
29. Long DM: Capillary ultrastructure in human metastatic brain tumors. J Nerosurg 51: 53-8, 1979
30. Anderson RE, Warner NL: Ionizing radiation and the immune response. Adv Immunol 24: 215-335, 1976